Table 3.
Outcome | Pathway | Count | Size | P-value | BH |
---|---|---|---|---|---|
OS | ErbB signaling pathway | 11 | 60 | 0.029 | 0.999 |
OS | Salivary secretion | 6 | 23 | 0.042 | 0.995 |
OS | Inflammatory mediator regulation of TRP channels | 9 | 48 | 0.049 | 0.983 |
EFS | Terpenoid backbone biosynthesis | 4 | 8 | 0.010 | 0.906 |
EFS | Metabolic pathways | 29 | 304 | 0.016 | 0.847 |
EFS | Valine, leucine and isoleucine degradation | 5 | 20 | 0.032 | 0.911 |
EFS | Biosynthesis of antibiotics | 12 | 98 | 0.037 | 0.882 |
EFS | Fatty acid metabolism | 5 | 21 | 0.037 | 0.820 |
In this analysis, the GeneCards genes are used at the background. The columns include survival outcome (OS or EFS), KEGG pathway name, the number of genes in the gene set that are in the pathway, the total number of genes annotated for the pathway, the p-value from a modified fisher’s exact test, and the Benjamini-Hochberg corrected p-value